Arya Health (Business/Productivity Software)

Website
Current Valuation
$73.0M
As of August 18, 2025
Total Funding Raised
$25.4M
Last Round
Early Stage VC

$18.2M

Last Funding
Aug 2025

Funding date

Capital Efficiency
2.87x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Arya Health (Business/Productivity Software) is currently valued at $73.0M as of August 18, 2025. The company has raised a total of $25.4M in funding.

Capital Efficiency

With a capital efficiency ratio of 2.87x, Arya Health (Business/Productivity Software) has achieved a valuation that is 2.87 times the total capital raised.

Track Arya Health (Business/Productivity Software) Valuation Updates

Get notified when Arya Health (Business/Productivity Software) raises new funding or valuation changes

Explore More Data
Detailed analysis for Arya Health (Business/Productivity Software)

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Arya Health (Business/Productivity Software)'s valuation history, funding rounds, and growth metrics.

No credit card required

What is Arya Health (Business/Productivity Software) Worth in 2026?

Arya Health (Business/Productivity Software) is a leading private company in the technology sector. Track Arya Health (Business/Productivity Software)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Arya Health (Business/Productivity Software) Valuation is Determined

Private company valuations like Arya Health (Business/Productivity Software)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.